Financials
| Final results for the year ended 31 December 2024 | Apr. 30, 2025 |
| Interim Results | Sep. 30, 2024 |
| Interim Results | Sep. 28, 2023 |
| Results for the year ended 31 December 2022 | Apr. 27, 2023 |
| Interim results | Sep. 28, 2022 |
| Results for the year ended 31 December 2021 | May. 30, 2022 |
| Interim Results | Sep. 30, 2021 |
Proxies
| Result of AGM | Jun. 30, 2025 |
| Notice of AGM | Jun. 06, 2025 |
| Result of AGM | Jun. 24, 2024 |
| Notice of Annual General Meeting | Jun. 03, 2024 |
| Result of AGM | Jun. 28, 2023 |
| Result of AGM | Jun. 27, 2022 |
| Posting of Annual Report and Notice of AGM | Jun. 01, 2022 |
Ownership Update
| Holding(s) in Company | May. 28, 2025 |
| Holding(s) in Company | Sep. 16, 2024 |
| Holding(s) in Company | May. 13, 2024 |
| Holding(s) in Company | Apr. 23, 2024 |
| Issue of Options in lieu of salary increases | Mar. 07, 2023 |
| Holding(s) in Company | Feb. 22, 2023 |
| Holding(s) in Company | Feb. 06, 2023 |
Announcements
| Contract in Caribbean and Update on CIZ1B | Apr. 28, 2025 |
| Launch of New Website | Apr. 14, 2025 |
| Appointment of Non-Executive Director | Mar. 25, 2025 |
| Update on Launch of CIZ1B Biomarker Assay | Mar. 24, 2025 |
| Appointment of Professor Dawn Coverley as CSO | Jan. 02, 2025 |
| Execution of Agreement for North America | Oct. 21, 2024 |
| Update on Licensing and Partnership Agreement | Oct. 03, 2024 |